language
Language
Englishchevron_right
attach_money
Currency
$USDchevron_right
dark_mode
Dark Mode
policy
Privacy Policy
gavel
Terms of Service
AMWLAMWL

$3.923

-0.19
arrow_drop_down4.55%
Current Market·update13 Nov 2025 18:56
Day's Range
3.91-4.055
52-week Range
3.87-12.95

Chart

Loading chart...

Performance

Key Stats

Next Earnings Date2025-11-04
Next Earnings TimeAfter Market Close
Volume89.73K
Average Volume 30d82.94K

AI AMWL Summary

Powered by LiveAI
💰
-0.79
Valuation (P/E Ratio)
Currently unprofitable, P/E ratio is not a useful metric.
📈
-70.96%
EPS Growth (YoY)
Significant decline in EPS year-over-year.
Show More 🔒

AI Scoreboard

Powered by LiveAI
🔒

Overall Analysis

Hold
58

American Well Corporation (AMWL) presents a mixed investment profile. While it operates in a growing market (telehealth), its financial performance, particularly profitability and cash flow, remains a significant concern. Technical indicators show some positive momentum, but fundamental weaknesses necessitate a cautious approach.

Moderate

Thematic

75

The demand for hybrid care and telehealth solutions is a strong secular trend, driven by convenience, cost-effectiveness, and technological advancements. AMWL is positioned within this growth sector.

Weak

Fundamental

45

AMWL's financials show persistent unprofitability and negative free cash flow, despite revenue growth. The balance sheet is manageable but heavily reliant on cash reserves, which have been declining. Valuation metrics are currently unfavorable given the lack of profitability.

Neutral

Technical

60

The stock has shown some positive short-term momentum, trading above key moving averages. However, indicators like RSI suggest it's approaching neutral territory after recent gains, implying potential for consolidation.

FactorScore
Digital Health Adoption85
Healthcare Access & Affordability80
Technological Innovation in Care Delivery70
Regulatory Landscape65
Competitive Environment70
FactorScore
Valuation40
Profitability10
Growth30
Balance Sheet Health50
Cash Flow20
FactorScore
Trend Analysis65
Momentum60
Volume Confirmation55
Support & Resistance60

AI Investing Checklist

Powered by LiveAI
thumb_up

Bullish Points (5)

Financial Health & Liquidity chevron_right

Strong Cash Position

The company maintains a significant cash and cash equivalents balance of $228.32 million as of Q4 2024, indicating a solid ability to fund operations and investments. [19, 22]

Valuation chevron_right

Attractive Price-to-Sales Ratio

The Price-to-Sales (P/S) ratio of 0.48 is below 1, suggesting the company may be undervalued relative to its sales, especially for a growth-oriented technology company. [6, 24]

Show More 🔒
thumb_down

Bearish Points (7)

Profitability chevron_right

Consistent Net Losses

American Well has consistently reported net losses, with a net income of -$208.14 million in 2024, indicating ongoing profitability challenges. [5, 23]

Profitability chevron_right

Negative Profit Margins

The company exhibits negative net profit margin (-59.14%) and operating margin (-60.08%), suggesting that costs are significantly outweighing revenues. [6]

Show More 🔒

Calendar

August 2025

6

Next Earnings Date

EPS Est.
Revenue Est.

H: $-1.07

A: $-1.11

L: $-1.15

H: 65.60M

A: 63.93M

L: 62.00M

Profile

Employees (FY)877
ISINUS03044L2043
FIGI-

American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Converge, a cloud-based platform that enables health providers, payers, and innovators to provide in-person, virtual and automated care; and delivers virtual primary care, post-discharge follow-up, chronic condition management, virtual nursing, e-sitting, on-demand and scheduled virtual visits, specialty consults, automated care, and behavioral health, as well as offers specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care for patients and members. It also provides Carepoint devices, which transforms proprietary carts, peripherals, tablets, and TVs into digital access points in clinical settings. In addition, the company offers Amwell Medical Group network services consisting of primary and urgent care, behavioral health therapy, lactation counseling, and nutrition services. Further, it provides professional services to facilitate implementation, workflow design, systems integration, and service expansion for its products, as well as patient and provider engagement services. The company sells its products through field sales professionals, channel partners, and value-added resellers. It serves providers, payers, and the government, as well as the higher education sector. American Well Corporation was incorporated in 2006 and is headquartered in Boston, Massachusetts.

Seasonals

2025
2024
2023
2022
2021

Price Target

10.33 USD

The 39 analysts offering 1 year price forecasts for AMWL have a max estimate of 15.00 and a min estimate of 7.50.

Debt Level and Coverage

Debt
Free cash flow
Cash & equivalents

Financial Position Analysis

Assets
Liabilities

Ownership

Free Float shares
12.1M (85.24%)
Closely held shares
2.09M (14.76%)
14.2M
Free Float shares
12.1M (85.24%)
Closely held shares
2.09M (14.76%)

Capital Structure

Market cap
126.89M
Debt
8.2M
Minority interest
0.00
Cash & equivalents
228.32M
Enterprise value
-93.22M

Valuation - Summary

Market Cap
142M
Net income
-105M(-74.00%)
Revenue
199M(140.40%)
142M
Market Cap
142M
Net income
-105M(-74.00%)
Revenue
199M(140.40%)
Price to earning ratio (P/E)-1.40x
Price to sales ratio (P/S)0.70x

Valuation - Ratios

P/E
P/S

Revenue to Profit Conversion

Revenue
254.36M
COGS
155.41M
Gross Profit
98.95M
OpEx
316.49M
Operating Income
-217.53M
Other & Taxes
-9.39M
Net Income
-208.14M

Balance Sheet

Total assets
Total liabilities
Liabilities to assets %

Income Statement

Revenue
Net Income
Net Margin

Cash Flow

Operating Cash Flow
Investing Cash Flow
Financing Cash Flow
Show More 🔒